Budesonide: A promising candidate therapeutic for early COVID-19.

Patel, Shailesh Kumar; Kumar, Rakesh; Rana, Jigyasa; Agrawal, Aditya; Singh, Alok; Kumar, Adesh

Patel, Shailesh Kumar; Kumar, Rakesh; Rana, Jigyasa; Agrawal, Aditya; Singh, Alok; Kumar, Adesh.

Patel SK; Department of Veterinary Pathology, College of Veterinary Science and Animal Husbandary, Bilaspur, CGKV, Chhattisgarh, India.
Kumar R; Department of Veterinary Pathology, Dr. G.C. Negi College of Veterinary and Animal Sciences, CSK Himachal Pradesh Agricultural University, Palampur, Himanchal Pradesh, India.
Rana J; Department of Veterinary Anatomy, Faculty of Veterinary and Animal Sciences, RGSC, BHU, Barkachha, Mirzapur, Uttar Pradesh, India.
Agrawal A; Division of Animal Biochemistry, ICAR- Indian Veterinary Research Institute, Bareilly, Izatnagar, Uttar Pradesh, India.
Singh A; Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India.
Kumar A; Veterinary Assistant Surgeon, Veterinary Hospital Aswar, Bhind, Madhya Pradesh, India.

Ann Med Surg (Lond) ; 68: 102605, 2021 Aug.

Artículo en Inglés | MEDLINE | ID: covidwho-1336208

Palabras clave

Budesonide; COVID-19; Clinical trial; Corticosteroid; Drug; Inhaled

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Idioma: Inglés Revista: Ann Med Surg (Lond) Año: 2021 Tipo del documento: Artículo País de afiliación: J.amsu.2021.102605

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google